There are 2789 resources available
1368TiP - EPROPA: The European program for routine testing of patients with advanced lung cancer
Presenter: Francesco Passiglia
Session: ePoster Display
1284P - Sitravatinib + tislelizumab in patients with anti-PD-(L)1 refractory/resistant metastatic NSCLC
Presenter: Bo Gao
Session: ePoster Display
1352P - A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Presenter: Giulia Mazzaschi
Session: ePoster Display
1371TiP - Radiotherapy combined with apatinib and PD-1 inhibitors in patients with brain metastases from non-small cell lung cancer: A single-arm exploratory clinical study
Presenter: Hongwei li
Session: ePoster Display
1286P - Senescent immune phenotype (SIP) status predicts resistance to immune checkpoint blockers (ICB) among CMV+ advanced non-small cell lung cancer (aNSCLC) patients
Presenter: Marie Naigeon
Session: ePoster Display
1287P - Immune T-cell subpopulations from the peripheral blood of non-small cell lung cancer patients are associated with the efficacy of anti-PD-1 immunotherapy
Presenter: Jacobo Rogado
Session: ePoster Display
1357P - A deep radiomics approach to assess PD-L1 expression and clinical outcomes in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors: A multicentric study
Presenter: Marion Tonneau
Session: ePoster Display
1291P - A phase II study of nivolumab rechallenge therapy in advanced NSCLC patients who responded to prior anti-PD-1/L1 inhibitors: West Japan Oncology Group 9616L
Presenter: Shunsuke Teraoka
Session: ePoster Display